Gelesis Holdings Inc
Biotechnology
Healthcare
traded
17 Aug 2022
listed
no
open
1.38
52 week high
9.99
high
1.41
52 week low
1.34
previous Close
1.40
P/E ratio
market cap
95.09 M
div yield
0
net incoming
-12.60 K
99.90 %
net profit margin
-140.40 %
-140.00 %
operating incoming
-34.35 K
99.83 %
net change in cash
-8.64 M
-3.00 %
cash on hand
25.34 K
-99.91 %
cost of revenue
4.79 K
-100.00 %
top